ArticleFrontiers in oncology2025
Case Report: Tumor-to-tumor metastasis: a rare case of prostate adenocarcinoma metastasis to lung squamous cell carcinoma in a patient with multiple primary malignancies.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tumor-to-tumor metastasis (TTM) is a rare occurrence in patients with two separate primary tumors, with the more malignant tumor more commonly metastasizing to a separate primary benign or low-grade tumor. Lung carcinomas are the most common metastatic tumor donors. However, the opposite phenomenon (lung carcinoma as a recipient of metastasis from prostate adenocarcinoma) is rarely previously reported in the literature. We report the case of TTM from prostate cancer to coexisting primary lung cancer. Case report: The 69-year-old male patient underwent surgery for tongue cancer on March 16, 2024, during which a lung mass was discovered in the right lower lung. The lung mass increased in size by follow-up thoracic computed tomography scan on October 4, 2024. Subsequently, the patient underwent single-port thoracoscopic right lower lung lobectomy and mediastinal lymph node dissection. Postoperative pathological results revealed that the lung mass had two components: lung squamous cell carcinoma and prostate cell carcinoma. MRI evaluation and PSA tests confirmed a prostate mass on November 8, 2024. Further, ultrasound-guided transperineal prostate biopsy was performed, and the biopsy pathology indicated prostate acinar adenocarcinoma. Subsequently, the patient underwent robot-assisted laparoscopic prostatectomy. Conclusions: This case report presents a rare and intriguing instance of TTM, specifically describing prostate adenocarcinoma metastasizing to a primary lung squamous cell carcinoma. The manuscript contributes valuable documentation to the limited literature on this rare phenomenon and is of potential interest to the oncology community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.